OSIA
DGX icon

O'Shares Investment Advisers’s Quest Diagnostics DGX Stock Holding History

O'Shares Investment Advisers’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,650
Closed -$2.14M – 65
2022
Q1 		$2.14M Buy
15,650
+882
+6% +$123K 0.17% 155
2021
Q4 		$2.56M Buy
14,768
+1,077
+8% +$164K 0.18% 156
2021
Q3 		$1.99M Buy
+13,691
New +$2M 0.15% 167

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

O'Shares Investment Advisers's DGX Position: Q2 2022 in Review

O'Shares Investment Advisers sold out of Quest Diagnostics (DGX) in Q2 2022, closing a stake of 15,650 shares — an estimated $2.14M sold.

O'Shares Investment Advisers first reported a position in DGX in Q3 2021 and held it in 3 quarters. The position peaked at $2.56M in Q4 2021. 852 funds tracked by Wall St. Rank hold DGX as of Q2 2022.

  • O'Shares Investment Advisers reported no remaining Quest Diagnostics position as of Q2 2022 after selling out during the quarter.
  • O'Shares Investment Advisers sold 15,650 Quest Diagnostics shares in Q2 2022, an estimated $2.14M.
  • O'Shares Investment Advisers first reported a position in Quest Diagnostics in Q3 2021 and held it in 3 quarters.
  • O'Shares Investment Advisers's Quest Diagnostics position peaked at $2.56M in Q4 2021.
  • 852 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.

Based on O'Shares Investment Advisers's 13F filing for Q2 2022.